王志度, 万进, 彭俊生, 林锋. 重组人生长激素与肠内营养支持在胃肠道肿瘤患者术后的应用[J]. 中国肿瘤临床, 2004, 31(19): 1091-1093.
引用本文: 王志度, 万进, 彭俊生, 林锋. 重组人生长激素与肠内营养支持在胃肠道肿瘤患者术后的应用[J]. 中国肿瘤临床, 2004, 31(19): 1091-1093.
Wang Zhidu, Wan Jin, Peng Junsheng, Lin Feng. Application of Recombinant Human Growth Hormone and Enteral Nutrition Support after Gastrointestinal Tumor Surgery[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(19): 1091-1093.
Citation: Wang Zhidu, Wan Jin, Peng Junsheng, Lin Feng. Application of Recombinant Human Growth Hormone and Enteral Nutrition Support after Gastrointestinal Tumor Surgery[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 31(19): 1091-1093.

重组人生长激素与肠内营养支持在胃肠道肿瘤患者术后的应用

Application of Recombinant Human Growth Hormone and Enteral Nutrition Support after Gastrointestinal Tumor Surgery

  • 摘要: 目的 :观察重组人生长激素(rhGH)和肠内营养支持(EN)在胃肠道肿瘤患者术后的应用效果。 方法 :19例患者接受。EN和rhGH(试验组),21例患者接受与试验组同样的EN(对照组)。 结果 :治疗前两纽患者血蛋白指标(白蛋白、前白蛋白、转铁蛋白)无明显差异,治疗后均升高,而试验组血蛋白指标的水平明显高于对照组(P<0.05),两者差异显著。术后第10天试验组疲劳度评分明显低于对照组。 结论 :胃肠道肿瘤患者术后应用rhGH和EN有利于促进蛋白质合成和减轻患者的疲劳度。

     

    Abstract: Objectives :To observe the role of recombinant human growth hormone (rhGH) and enteral nutrition (EN) support after gastrointestinal tumor surgery. Methods :Nineteen cases of patients received enteral nutrition and rhGH (experiment group).Twenty-one cases of patients undewrent the same enterral nutrition as experiment group (control group). Results : Befor treating, there was no significant difference between the two groups in the plasma protein (albumin 、preprotein、transferrin)·The level of plasma proteins was increased in the two groups, but the change in experiment group was more significant than that in control group (P<0.05).Score of postoperative fatigue(POF) in experiment group on day 10 after operation was lower significantly than that in control group (P<0.05). Conclusion :combined treatment using rhGH and EN could obviously promote protein synthesis,and the patients with rhGH after gastrointestinal tumor surgery can recover more rapidly from POF.

     

/

返回文章
返回